You are here: Industry Insights > US

News List

US Scientists uncover new strategy for stopping breast cancer biospectrumasia
March 23, 2018
Discovery opens door to drugs that could stop breast cancer tumors from growing and spreading - potentially saving women's lives worldwide
Progress Prospects for Regulations in China, U.S. and EU in 2018 zhulikou431
March 15, 2018
The drug administration of each country has introduced their work plan for 2018 legislation or regulation revision and update, etc. in the spring of 2018.
Lupin launches generic Namenda XR capsules in the US biospectrumasia
February 26, 2018
It is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type
Who can expect the biggest hit under the Senate's budget deal? fiercepharma
February 13, 2018
Pharma will pay more under the new budget deal - and some long-suffering pharmas will pay the most
Report shows less asthma attacks in US children pharmaceutical-technology
February 08, 2018
A new report by the US Centers for Disease Control and Prevention (CDC) has shown that children with asthma are having fewer attacks and less visits to the hospital.
Lupin Pharmaceuticals recalls 12,888 bottles of ulcer drug in US expressbpd
September 15, 2017
Drug firm Lupin’s US arm, Lupin Pharmaceuticals, is recalling 12,888 bottles of Famotidine for oral suspension used in treatment of ulcers from the American market.
Jubilant Pharma buys US radiopharmacy business of Triad Isotopes expressbpd
September 04, 2017
The acquired radiopharmacies will continue to operate independently under the brand name of Triad Isotopes
US clears new antibiotic for UTIs pharmatimes
September 04, 2017
The US Food and Drug Administration has approved a new antibacterial drug to treat patients with complicated urinary tract infections (UTI).
Roche’s Herceptin facing further biosimilar threats in US pharmaphorum
August 03, 2017
Roche’s breast cancer blockbuster Herceptin could face further competition in the US when its patent expires in the coming years...
US ophthalmic drugs market set to pass $34bn by 2025 europeanpharmaceuticalreview
July 26, 2017
Major market players across the US are upping investments in research to innovate on treatment methods and improve ophthalmic drugs action…

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page